The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Asthma Drugs-Global Market Insights and Sales Trends 2024
Synopsis
Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors.
The global Asthma Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Asthma Drugs in various end use industries. The expanding demands from the Allergic Asthma and Non-Allergic Asthma, are propelling Asthma Drugs market. Quick-relief Medications (Rescue Medications), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Medications for Allergy-induced Asthma segment is estimated at % CAGR for the next seven-year period.
The American Academy of Allergy Asthma and Immunology classifies asthma under four categories: exercise-induced asthma, allergic asthma, occupational asthma, and childhood asthma. The Asthma and Allergy Foundation of America classifies asthma into two categories: allergic asthma and non-allergic asthma. It is an incurable disease but can be controlled with the help of diagnosis at the right time, followed by regular therapy.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Asthma Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Asthma Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Asthma Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Asthma Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Asthma Drugs covered in this report include Pfizer, GlaxoSmithKline, Novartis, Merck, Boehringer Ingelheim, AstraZeneca, Roche, Teva Pharmaceutical and Vectura Group, etc.
The global Asthma Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
GlaxoSmithKline
Novartis
Merck
Boehringer Ingelheim
AstraZeneca
Roche
Teva Pharmaceutical
Vectura Group
Global Asthma Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Asthma Drugs market, Segment by Type:
Quick-relief Medications (Rescue Medications)
Medications for Allergy-induced Asthma
Global Asthma Drugs market, by Application
Allergic Asthma
Non-Allergic Asthma
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Asthma Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Asthma Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors.
The global Asthma Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Asthma Drugs in various end use industries. The expanding demands from the Allergic Asthma and Non-Allergic Asthma, are propelling Asthma Drugs market. Quick-relief Medications (Rescue Medications), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Medications for Allergy-induced Asthma segment is estimated at % CAGR for the next seven-year period.
The American Academy of Allergy Asthma and Immunology classifies asthma under four categories: exercise-induced asthma, allergic asthma, occupational asthma, and childhood asthma. The Asthma and Allergy Foundation of America classifies asthma into two categories: allergic asthma and non-allergic asthma. It is an incurable disease but can be controlled with the help of diagnosis at the right time, followed by regular therapy.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Asthma Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Asthma Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Asthma Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Asthma Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Asthma Drugs covered in this report include Pfizer, GlaxoSmithKline, Novartis, Merck, Boehringer Ingelheim, AstraZeneca, Roche, Teva Pharmaceutical and Vectura Group, etc.
The global Asthma Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
GlaxoSmithKline
Novartis
Merck
Boehringer Ingelheim
AstraZeneca
Roche
Teva Pharmaceutical
Vectura Group
Global Asthma Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Asthma Drugs market, Segment by Type:
Quick-relief Medications (Rescue Medications)
Medications for Allergy-induced Asthma
Global Asthma Drugs market, by Application
Allergic Asthma
Non-Allergic Asthma
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Asthma Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Asthma Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Asthma Drugs Market Overview
1.1 Asthma Drugs Product Overview
1.2 Asthma Drugs Market Segment by Type
1.2.1 Quick-relief Medications (Rescue Medications)
1.2.2 Medications for Allergy-induced Asthma
1.3 Global Asthma Drugs Market Size by Type
1.3.1 Global Asthma Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Asthma Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Asthma Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Asthma Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Asthma Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Asthma Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Asthma Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Asthma Drugs Sales Breakdown by Type (2018-2023)
2 Global Asthma Drugs Market Competition by Company
2.1 Global Top Players by Asthma Drugs Sales (2018-2023)
2.2 Global Top Players by Asthma Drugs Revenue (2018-2023)
2.3 Global Top Players by Asthma Drugs Price (2018-2023)
2.4 Global Top Manufacturers Asthma Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Asthma Drugs Market Competitive Situation and Trends
2.5.1 Asthma Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Asthma Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Asthma Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Asthma Drugs Market
2.8 Key Manufacturers Asthma Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Asthma Drugs Status and Outlook by Region
3.1 Global Asthma Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Asthma Drugs Historic Market Size by Region
3.2.1 Global Asthma Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Asthma Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Asthma Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Asthma Drugs Forecasted Market Size by Region
3.3.1 Global Asthma Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Asthma Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Asthma Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Asthma Drugs by Application
4.1 Asthma Drugs Market Segment by Application
4.1.1 Allergic Asthma
4.1.2 Non-Allergic Asthma
4.2 Global Asthma Drugs Market Size by Application
4.2.1 Global Asthma Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Asthma Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Asthma Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Asthma Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Asthma Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Asthma Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Asthma Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Asthma Drugs Sales Breakdown by Application (2018-2023)
5 North America Asthma Drugs by Country
5.1 North America Asthma Drugs Historic Market Size by Country
5.1.1 North America Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Asthma Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Asthma Drugs Sales in Value by Country (2018-2023)
5.2 North America Asthma Drugs Forecasted Market Size by Country
5.2.1 North America Asthma Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Asthma Drugs Sales in Value by Country (2024-2029)
6 Europe Asthma Drugs by Country
6.1 Europe Asthma Drugs Historic Market Size by Country
6.1.1 Europe Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Asthma Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Asthma Drugs Sales in Value by Country (2018-2023)
6.2 Europe Asthma Drugs Forecasted Market Size by Country
6.2.1 Europe Asthma Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Asthma Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Asthma Drugs by Region
7.1 Asia-Pacific Asthma Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Asthma Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Asthma Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Asthma Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Asthma Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Asthma Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Asthma Drugs Sales in Value by Region (2024-2029)
8 Latin America Asthma Drugs by Country
8.1 Latin America Asthma Drugs Historic Market Size by Country
8.1.1 Latin America Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Asthma Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Asthma Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Asthma Drugs Forecasted Market Size by Country
8.2.1 Latin America Asthma Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Asthma Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Asthma Drugs by Country
9.1 Middle East and Africa Asthma Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Asthma Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Asthma Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Asthma Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Asthma Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Asthma Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Asthma Drugs Products Offered
10.1.5 Pfizer Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Company Information
10.2.2 GlaxoSmithKline Introduction and Business Overview
10.2.3 GlaxoSmithKline Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GlaxoSmithKline Asthma Drugs Products Offered
10.2.5 GlaxoSmithKline Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novartis Asthma Drugs Products Offered
10.3.5 Novartis Recent Development
10.4 Merck
10.4.1 Merck Company Information
10.4.2 Merck Introduction and Business Overview
10.4.3 Merck Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck Asthma Drugs Products Offered
10.4.5 Merck Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Company Information
10.5.2 Boehringer Ingelheim Introduction and Business Overview
10.5.3 Boehringer Ingelheim Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Boehringer Ingelheim Asthma Drugs Products Offered
10.5.5 Boehringer Ingelheim Recent Development
10.6 AstraZeneca
10.6.1 AstraZeneca Company Information
10.6.2 AstraZeneca Introduction and Business Overview
10.6.3 AstraZeneca Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 AstraZeneca Asthma Drugs Products Offered
10.6.5 AstraZeneca Recent Development
10.7 Roche
10.7.1 Roche Company Information
10.7.2 Roche Introduction and Business Overview
10.7.3 Roche Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Roche Asthma Drugs Products Offered
10.7.5 Roche Recent Development
10.8 Teva Pharmaceutical
10.8.1 Teva Pharmaceutical Company Information
10.8.2 Teva Pharmaceutical Introduction and Business Overview
10.8.3 Teva Pharmaceutical Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Teva Pharmaceutical Asthma Drugs Products Offered
10.8.5 Teva Pharmaceutical Recent Development
10.9 Vectura Group
10.9.1 Vectura Group Company Information
10.9.2 Vectura Group Introduction and Business Overview
10.9.3 Vectura Group Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Vectura Group Asthma Drugs Products Offered
10.9.5 Vectura Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Asthma Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Asthma Drugs Industrial Chain Analysis
11.4 Asthma Drugs Market Dynamics
11.4.1 Asthma Drugs Industry Trends
11.4.2 Asthma Drugs Market Drivers
11.4.3 Asthma Drugs Market Challenges
11.4.4 Asthma Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Asthma Drugs Distributors
12.3 Asthma Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
